PROSPECTS AND OPPORTUNITIES
Dengue outbreak may boost demand for acetaminophen
Retail sales of analgesics in Uruguay are projected to grow modestly in constant value terms (at 2025 prices) over the forecast period. The Ministry of Health has warned that 2025 could see record levels of dengue, a mosquito-borne disease that is increasingly linked to climate change.
Herbal/traditional products may benefit from growing interest in natural alternatives
While conventional capsule analgesics dominate usage in Uruguay, herbal and traditional remedies are gaining traction as alternative options. Driven by increasing awareness of preventative health and overall wellbeing, more consumers are exploring natural solutions instead of conventional OTC products.
E-commerce presents opportunities to boost analgesic consumption
The rapid growth of e-commerce offers new avenues for the promotion and sale of analgesics, creating opportunities to broaden consumer access and adoption. Online platforms have the advantage of being able to showcase a wide range of products and provide detailed information, helping consumers become more familiar the different types of analgesics available.
Delivery:
Files are delivered directly into your account soon after payment is received and any tax is certification is verified (where applicable).
This report comes in PDF with additional info in Excel included.
Overview:
Understand the latest market trends and future growth opportunities for the Analgesics industry in Uruguay with research from Euromonitor International's team of in-country analysts – experts by industry and geographic specialisation.
Key trends are clearly and succinctly summarised alongside the most current research data available. Understand and assess competitive threats and plan corporate strategy with our qualitative analysis, insight and confident growth projections.
If you're in the Analgesics industry in Uruguay, our research will help you to make informed, intelligent decisions; to recognise and profit from opportunity, or to offer resilience amidst market uncertainty.
The Analgesics in Uruguay report includes:
- Analysis of key supply-side and demand trends
- Detailed segmentation of international and local products
- Historic volume and value sizes, company and brand market shares
- Five year forecasts of market trends and market growth
- Robust and transparent research methodology, conducted in-country
This report answers:
- What is the market size of Analgesics in Uruguay?
- Which are the leading brands in Analgesics in Uruguay?
- How are products distributed in Analgesics in Uruguay?
- How has the regulatory and operating environment for Analgesics changed in Uruguay?
- How are considerations such as stress, self-medication and shifting consumer lifestyles shaping demand for Analgesics
- How significant are wider health concerns and consumer awareness in determining sales?
- Where is future growth expected to be most dynamic?
Analgesics in Uruguay - Category analysis
KEY DATA FINDINGS
Improved performance as cross-border purchases decline
Gramon Bago Uruguay retains leadership, underpinned by wide portfolio and investment in new product development
Pharmacies control sales while e-commerce gains share
Dengue outbreak may boost demand for acetaminophen
Herbal/traditional products may benefit from growing interest in natural alternatives
E-commerce presents opportunities to boost analgesic consumption
Consumer Health in Uruguay - Industry Overview
Consumer Health in 2025: The big picture
Key trends in 2025
Competitive landscape
Channel developments
What next for consumer health?
OTC registration and classification
Vitamins and dietary supplements registration and classification
Self-medication/self-care and preventive medicine
Switches
DISCLAIMER
DEFINITIONS
The following categories and subcategories are included:
Analgesics
-
-
- Adult Acetaminophen
- Adult Aspirin
- Adult Combination Products - Analgesics
- Adult Diclofenac
- Adult Dipyrone
- Adult Ibuprofen
- Adult Ketoprofen
- Adult Naproxen
- Adult OTC Triptans
-
- Paediatric Acetaminophen
- Paediatric Aspirin
- Paediatric Combination Products - Analgesics
- Paediatric Dipyrone
- Paediatric Ibuprofen
- Paediatric Naproxen
-
- Acetaminophen
- Aspirin
- Combination Products - Analgesics
- Diclofenac
- Dipyrone
- Ibuprofen
- Ketoprofen
- Naproxen
- OTC Triptans
-
- Topical Analgesics/Anaesthetic
Analgesics
Analgesics cover systemic and topical pain relievers. Products which include a pain-relief ingredient in addition to another core function are excluded (e.g. a sore throat remedy which includes paracetamol is excluded from the analgesics and instead is included in pharyngeal remedies).
See all of our definitionsWhy buy this report?
- Gain competitive intelligence about market leaders
- Track key industry trends, opportunities and threats
- Inform your marketing, brand, strategy and market development, sales and supply functions
This report originates from Passport, our Analgesics research and analysis database.
NEW REPORT GUARANTEE
If you purchase a report that is updated in the next 60 days, we will send you the new edition and data extraction Free!